ArticleJournal of electrical bioimpedance2019
Recognition of Lung Volume Condition based on Phase Space Mapping Using Electrical Impedance Tomography.
Article in Journal of electrical bioimpedance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this paper is to identify differences between abnormal and normal lung signals gathered by an EIT device, which is a new, non-invasive system that seeks the electrical conductivity and permittivity inside a body. Lung performances in patients are investigated using Phase Space Mapping technique on Electrical EIT signals. The database used in this paper contains 82 registered records of 52 individuals with proper lung volume. The results of this paper show that as the delay parameter (τ) increases, the SD1 parameter of phase space mapping indicates a significant difference between normal and abnormal lung volumes. The value of the SD1 parameter with τ = 6 in the case that the lung volume is in a normal condition is 342.57 ± 32.75 while it is 156.71 ± 26.01 in non-optimal mode. This method can be used to identify the patients' lung volumes with chronic respiratory illnesses and is an accurate assessment of the diverse methods to treat respiratory system illnesses in addition to saving various therapeutic costs and dangerous consequences that are likely to occur by using improper treatment methods. It can also reduce the required treatment durations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.